Skip to main content
Equibles

CENTAURUS FINANCIAL, INC.

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 891943 ANAHEIM, CA
Back to AUPH Full portfolio

Position in AUPH

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$1,112,824
+$208,508 QoQ
Shares Held
65,576
+7.5% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#100
of 283 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in AUPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CENTAURUS FINANCIAL, INC. holds $5,779,268 across 11 Biotechnology names. AUPH ranks #3 (19.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 23,928 $1,872,844
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,749 $1,365,510
3 AUPH
Aurinia Pharmaceuticals Inc.
This page 		65,576 $1,112,824
4 MDGL
Madrigal Pharmaceuticals, Inc.
 721 $387,140
5 MRNA
Moderna, Inc.
 4,477 $313,524
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,454 $272,467
7 ARWR
Arrowhead Pharmaceuticals, Inc.
 1,774 $144,598
8 ROIV
Roivant Sciences Ltd.
 3,554 $125,776

All Filings in AUPH

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,112,824 65,576
2026-03-31 $904,316 61,020